Recruiting Eligible Patients at U.S. Sites
A Phase 1 Study of Autologous Desmoglein 3 Chimeric Autoantibody Receptor T Cells (DSG3-CAART) in Mucosal Pemphigus Vulgaris, Sponsored by Cabaletta Bio, Inc.
Clinical Trial Inquiries
Are you wondering if this clinical trial is right for you? A representative from our patient recruitment center would be glad to discuss the study with you. Alternatively, please email the Cabaletta Study Team.
Cabaletta Study Team:
Patient Recruitment Center Contact Information:
*Please include only your name and telephone number in the email. Someone from the recruitment center will contact you to discuss the study.